Effects of combination therapy with vildagliptin and valsartan in a mouse model of type 2 diabetes

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors modulate incretin hormones and exert anti-diabetic effects in type 2 diabetes mellitus. Treatment with angiotensin II type 1 receptor blockers (ARB) is a proven successful intervention for hypertension with type 2 diabetes. The present study inve...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Miyagawa, Katsutoshi, Kondo, Tatsuya, Goto, Rieko, Matsuyama, Rina, Ono, Kaoru, Kitano, Sayaka, Kawasaki, Shuji, Igata, Motoyuki, Kawashima, Junji, Matsumura, Takeshi, Motoshima, Hiroyuki, Araki, Eiichi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2013
Gaiak:
Original Investigation
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4176757/
https://ncbi.nlm.nih.gov/pubmed/24188631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-12-160
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak